The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2023

Filed:

Jul. 31, 2020
Applicant:

Gadeta B.v., Utrecht, NL;

Inventors:

Jürgen Herbert Ernst Kuball, Hilversum, NL;

Victoria Marcu, Givatayim, IL;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01); G01N 33/50 (2006.01); C07K 14/725 (2006.01); G01N 33/68 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
G01N 33/5011 (2013.01); A61K 35/17 (2013.01); C07K 14/7051 (2013.01); C12N 5/0636 (2013.01); C12N 15/85 (2013.01); G01N 33/505 (2013.01); G01N 33/6866 (2013.01); A61K 38/00 (2013.01); C12N 2510/00 (2013.01);
Abstract

The current invention provides methods to identify γ9δ2T-cell receptors (γ9δ2TCR) that mediate anti-tumour responses. Surprisingly, it was now found that the CDR3 regions of the γ9-T-cell receptor chain and the δ2-T-Cell receptor chain (δ2TCR chain) are of importance. Based on these findings, combinatorial-γδTCR-chain-exchange (CTE) is proposed as an efficient method for identifying γ9δ2TCRs that mediate anti-tumour responses. Using the method of the invention, specific sequences of the respective γ9TCR and δ2TCR chains were identified that mediate anti-tumour responses. Hence, the invention further provides for specific γ9δ2TCRs, or fragments thereof, that may be used e.g. in diagnostics or treatment of cancer. The invention further provides for nucleic acid sequences, genetic constructs and retroviral vectors that can be used to express the γ9δ2TCRs according to the invention.


Find Patent Forward Citations

Loading…